CC-3, an IgG-based B7-H3xCD3 bispecific antibody for targeting of gastrointestinal cancers

被引：0
|
作者：
Zekri, Latifa [1 ]
Lutz, Martina S. [1 ]
Hagelstein, Ilona [1 ]
Manz, Timo [2 ]
Engel, Monika [1 ]
Klimovich, Boris [1 ]
Prakash, Nisha [1 ]
Chashchina, Anna [1 ]
Hoerner, Sebastian [1 ]
Mueller, Stefanie [1 ]
Maerklin, Melanie [1 ]
Pfluegler, Martin [1 ]
Jung, Gundram [1 ]
Salih, Helmut R. [1 ]
机构：
[1] German Canc Res Ctr DKTK, Tubingen, Germany
[2] Eberhard Karls Univ Tuebingen, Tubingen, Germany
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2865
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo
    Juan Ma
    Tengfei Shang
    Pan Ma
    Xin Sun
    Jin Zhao
    Ximing Sun
    Man Zhang
    Investigational New Drugs, 2019, 37 : 1036 - 1043
  • [42] Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo
    Ma, Juan
    Shang, Tengfei
    Ma, Pan
    Sun, Xin
    Zhao, Jin
    Sun, Ximing
    Zhang, Man
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (05) : 1036 - 1043
  • [43] CLN-049 is a bispecific T cell engaging IgG-like antibody targeting FLT3 on AML cells
    Meetze, Kristan
    Mehta, Naveen K.
    Pfluegler, Martin
    Li, Bochong
    Baeuerle, Patrick A.
    Michaelson, Jennifer S.
    Jung, Gundram
    Salih, Helmut
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Soluble B7 homolog 3, sB7-H3, is a promising plasma biomarker in various solid cancers
    Tanaka, Hiroyuki
    Kondo, Tadanori
    Kato, Kazunori
    CANCER SCIENCE, 2018, 109 : 722 - 722
  • [45] High efficacy of a bispecific single-chain antibody construct (bscCD19xCD3) in a human B-cell lymphoma xenograft.
    Fichtner, I
    Bargou, R
    Schlereth, B
    Baeuerle, P
    Dreier, T
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6226S - 6227S
  • [46] Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody
    Liu, Xianglei
    Zhelev, Doncho
    Adams, Cynthia
    Chen, Chuan
    Mellors, John W.
    Dimitrov, Dimiter S.
    TRANSLATIONAL ONCOLOGY, 2021, 14 (12):
  • [47] A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC
    Wu, Huiting
    Liu, Chang
    Yuan, Qiang
    Qiao, Yan
    Ding, Yongwei
    Duan, Lina
    Li, Wenjing
    Zhang, Mengjia
    Zhang, Xuhua
    Jiang, Yanan
    Lu, Jing
    Dong, Ziming
    Wang, Tao
    Liu, Kangdong
    Zhao, Jimin
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [48] B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
    Hagelstein, Ilona
    Engel, Monika
    Hinterleitner, Clemens
    Manz, Timo
    Maerklin, Melanie
    Jung, Gundram
    Salih, Helmut R.
    Zekri, Latifa
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
    Kasten, Benjamin B.
    Gangrade, Abhishek
    Kim, Harrison
    Fan, Jinda
    Ferrone, Soldano
    Ferrone, Cristina R.
    Zinn, Kurt R.
    Buchsbaum, Donald J.
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 58 : 67 - 73
  • [50] Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96
    Fauci, Janelle M.
    Sabbatino, Francesco
    Wang, YangYang
    Londono-Joshi, Angelina I.
    Straughn, J. Michael, Jr.
    Landen, Charles N.
    Ferrone, Soldano
    Buchsbaum, Donald J.
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 203 - 210
12345